secwatch / observer
8-K filed May 01, 2026 23:59 UTC ticker ZSQR CIK 0001759186
m_and_a confidence high sentiment positive materiality 0.85

Z Squared to acquire Skycore Digital for up to $22M in Series B Preferred; new CEO and board installed

Z Squared Inc.

item 1.01item 3.02item 5.02item 7.01item 8.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Michelle Burke

Co-Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
Effective
2026-04-27
Filed
May 01, 2026 23:59 UTC
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed

Ryan Schadel

Chief Marketing Officer
Coeptis Therapeutics Holdings, Inc.
Effective
2026-04-27
Filed
May 01, 2026 23:59 UTC
In addition, on April 27, 2026, the Board appointed Ryan Schadel to serve as Chief Marketing Officer of the Company.
Appointed

Elissa Stall

Corporate Secretary
Coeptis Therapeutics Holdings, Inc.
Effective
2026-04-27
Filed
May 01, 2026 23:59 UTC
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed

Brian Cogley

Chief Financial Officer
Coeptis Therapeutics Holdings, Inc.
Effective
2026-04-27
Filed
May 01, 2026 23:59 UTC
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Appointed

David Halabu

Co-Chief Executive Officer
Coeptis Therapeutics Holdings, Inc.
Effective
2026-04-27
Filed
May 01, 2026 23:59 UTC
On April 27, 2026, the Board appointed each of the following individuals to serve in the office set forth opposite his or her name, in each case to hold office at the pleasure of the Board (subject to the terms of any applicable employment or service agreement): • David Halabu — Co-Chief Executive Officer (principal executive officer); • Michelle Burke — Co-Chief Executive Officer (principal executive officer); • Brian Cogley — Chief Financial Officer (principal financial officer); and • Elissa Stall — Corporate Secretary.
Source: SEC EDGAR
accession 0001683168-26-003426
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.